Fresenius Gets Defense Verdict In NaturaLyte MDL Wrongful Death Trial

(March 7, 2017, 12:27 PM EST) -- BOSTON — A Massachusetts federal jury on March 3 returned a defense verdict for Fresenius Medical Care Holding Inc., finding that the plaintiffs failed to show by a preponderance of evidence that the company’s NaturaLyte kidney dialysis solution was the proximate cause of the patient’s death (Florella Dial, et al. v. Fresenius Medical Care Holdings, Inc., et al., No. 14-11101, D. Mass.)....

Attached Documents

Related Sections